The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Body mass index, not dyslipidemia, is an independent predictor of survival in amyotrophic lateral sclerosis
Open accessAbstract
Introduction: Recent studies have provided conflicting data regarding the role of dyslipidemia in amyotrophic lateral sclerosis (ALS). The aim of this study was to determine whether cholesterol level are an independent predictor of survival in ALS. Methods: Cholesterol levels were measured in 427 ALS subjects from three clinical trial databases. Results: The LDL/HDL ratio did not decrease over time, despite significant declines in body mass index (BMI), forced vital capacity (FVC), and ALSFRS‐R. After adjusting for BMI, FVC, and age, the lipid ratio was not associated with survival. There was a “U”‐shaped association between BMI and mortality, with the highest survival at 30–35 kg/m 2. The adjusted hazard ratio for the linear association between BMI and survival was 0.860 (95% CI 0.80–0.93, P = 0.0001). Conclusions: We found that dyslipidemia is not an independent predictor of survival in ALS. BMI is an independent prognostic factor for survival after adjusting for markers of disease severity. Muscle Nerve, 2011
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis
Brooks, B. R., Miller, R. G., Swash, M., & Munsat, T. L. (2000) · Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders · doi:10.1080/146608200300079536 · Cited by 5,433
Dyslipidemia is a protective factor in amyotrophic lateral sclerosis
Dupuis, L., Corcia, P., Fergani, A., Gonzalez De Aguilar, J. L., Bonnefont-Rousselot, D., Bittar, R., Seilhean, D., Hauw, J. J., Lacomblez, L., Loeffler, J. P., et al. (2008) · Neurology · doi:10.1212/01.wnl.0000285080.70324.27 · Cited by 552
Energy metabolism in amyotrophic lateral sclerosis
Dupuis, L., Pradat, P.-F., Ludolph, A. C., & Loeffler, J.-P. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70224-6 · Cited by 537
Nutritional status is a prognostic factor for survival in ALS patients
Desport, J. C., Preux, P. M., Truong, T. C., Vallat, J. M., Sautereau, D., & Couratier, P. (1999) · Neurology · doi:10.1212/wnl.53.5.1059 · Cited by 486
Factors correlated with hypermetabolism in patients with amyotrophic lateral sclerosis
Desport, J. C., Preux, P. M., Magy, L., Boirie, Y., Vallat, J. M., Beaufrère, B., & Couratier, P. (2001) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/74.3.328 · Cited by 351
Hypermetabolism in ALS patients: an early and persistent phenomenon
Bouteloup, C., Desport, J.-C., Clavelou, P., Guy, N., Derumeaux-Burel, H., Ferrier, A., & Couratier, P. (2009) · Journal of Neurology · doi:10.1007/s00415-009-5100-z · Cited by 344
Trial of celecoxib in amyotrophic lateral sclerosis
Cudkowicz, M. E., Shefner, J. M., Schoenfeld, D. A., Zhang, H., Andreasson, K. I., Rothstein, J. D., Drachman, D. B., & Northeast ALS Consortium (2006) · Annals of Neurology · doi:10.1002/ana.20903 · Cited by 301
Self-citationKasarskis, E., Berryman, S., Vanderleest, J., Schneider, A., & McClain, C. (1996) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/63.1.130 · Cited by 293
A ketogenic diet as a potential novel therapeutic intervention in amyotrophic lateral sclerosis
Zhao, Z., Lange, D. J., Voustianiouk, A., MacGrogan, D., Ho, L., Suh, J., Humala, N., Thiyagarajan, M., Wang, J., & Pasinetti, G. M. (2006) · BMC Neuroscience · doi:10.1186/1471-2202-7-29 · Cited by 286
Dorst, J., Kühnlein, P., Hendrich, C., Kassubek, J., Sperfeld, A. D., & Ludolph, A. C. (2011) · Journal of Neurology · doi:10.1007/s00415-010-5805-z · Cited by 263
Premorbid weight, body mass, and varsity athletics in ALS
Scarmeas, N., Shih, T., Stern, Y., Ottman, R., & Rowland, L. P. (2002) · Neurology · doi:10.1212/wnl.59.5.773 · Cited by 246
Hypermetabolism in ALS: Correlations with Clinical and Paraclinical Parameters
Desport, J.-C., Torny, F., Lacoste, M., Preux, P.-M., & Couratier, P. (2005) · Neurodegenerative Diseases · doi:10.1159/000089626 · Cited by 234
A randomized, placebo-controlled trial of topiramate in amyotrophic lateral sclerosis
Cudkowicz, M. E., Shefner, J. M., Schoenfeld, D. A., Brown Jr., R. H., Johnson, H., Qureshi, M., Jacobs, M., Rothstein, J. D., Appel, S. H., Pascuzzi, R. M., et al. (2003) · Neurology · doi:10.1212/wnl.61.4.456 · Cited by 203
Self-citationNutritional assessment and survival in ALS patients
Claude Desport, P. M. P. (2000) · Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders · doi:10.1080/14660820050515386 · Cited by 198
Lower serum lipid levels are related to respiratory impairment in patients with ALS
Chiò, A., Calvo, A., Ilardi, A., Cavallo, E., Moglia, C., Mutani, R., Palmo, A., Galletti, R., Marinou, K., Papetti, L., et al. (2009) · Neurology · doi:10.1212/wnl.0b013e3181c1df1e · Cited by 165
Jawaid, A., Murthy, S. B., Wilson, A. M., Qureshi, S. U., Amro, M., Wheaton, M. W., Simpson, E. P., Harati, Y., Strutt, A. M., York, M. K., et al. (2010) · Amyotrophic Lateral Sclerosis · doi:10.3109/17482968.2010.482592 · Cited by 146
Increased peripheral lipid clearance in an animal model of amyotrophic lateral sclerosis
Fergani, A., Oudart, H., de Aguilar, J. G., Fricker, B., René, F., Hocquette, J.-F. J.-F., Meininger, V., Dupuis, L., & Loeffler, J. (2007) · Journal of Lipid Research · doi:10.1194/jlr.m700017-jlr200 · Cited by 131
Zoccolella, S., Beghi, E., Palagano, G., Fraddosio, A., Samarelli, V., Lamberti, P., Lepore, V. L., Serlenga, L., & Logroscino, G. (2006) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2006.06.027 · Cited by 124
Energy Intake and Amyotrophic Lateral Sclerosis
Mattson, M. P., Cutler, R. G., & Camandola, S. (2006) · NeuroMolecular Medicine · doi:10.1385/nmm:9:1:17 · Cited by 120
Brownell, K. D. (1981) · Archives of Internal Medicine · doi:10.1001/archinte.1981.00340090038010 · Cited by 110
Latent Cluster Analysis of ALS Phenotypes Identifies Prognostically Differing Groups
Ganesalingam, J., Stahl, D. R., Wijesekera, L. C., Galtrey, C. M., Shaw, C. E., Leigh, P. N., & Al‐Chalabi, A. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007107 · Cited by 69
Tisi, G. M., Conrique, A., Barrett-Connor, E. L., & Grundy, S. M. (1981) · Metabolism · doi:10.1016/0026-0495(81)90113-x · Cited by 48
Cited by
ESPEN guideline clinical nutrition in neurology
Burgos, R., Bretón, I., Cereda, E., Desport, J. C., Dziewas, R., Genton, L., Gomes, F., Jésus, P., Leischker, A., Muscaritoli, M., et al. (2018) · Clinical Nutrition · doi:10.1016/j.clnu.2017.09.003 · Cited by 571
Neuronal Lipid Metabolism: Multiple Pathways Driving Functional Outcomes in Health and Disease
Tracey, T. J., Steyn, F. J., Wolvetang, E. J., & Ngo, S. T. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00010 · Cited by 433
Clinical perspective on oxidative stress in sporadic amyotrophic lateral sclerosis
D’Amico, E., Factor-Litvak, P., Santella, R. M., & Mitsumoto, H. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.06.029 · Cited by 321
The Role of Leptin and Adiponectin in Obesity-Associated Cognitive Decline and Alzheimer’s Disease
Forny-Germano, L., De Felice, F. G., & Vieira, M. N. D. N. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.01027 · Cited by 297
The PRO-ACT database: Design, initial analyses, and predictive features
Atassi, N., Berry, J., Shui, A., Zach, N., Sherman, A., Sinani, E., Walker, J., Katsovskiy, I., Schoenfeld, D., Cudkowicz, M., et al. (2014) · Neurology · doi:10.1212/wnl.0000000000000951 · Cited by 285
Self-citation
Metadata
- Authors
- Paganoni, S., Deng, J., Jaffa, M., Cudkowicz, M. E., & Wills, A.
- Venue
- Muscle & Nerve
- Publisher
- Wiley
- Published
- 2011-05-23
- Volume
- 44
- Issue
- 1
- Pages
- 20-24
- ISSN
- 0148-639X (ISSN-L)
- 1097-4598
- OpenAlex
- W2131177410
- Cited by
- 293
- References
- 22
- FWCI
- 8.96
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.